GUILFORD, Conn., Jan. 11, 2021 /PRNewswire/ -- Butterfly Network, Inc., an innovative digital health company that is working to enable universal access to superior medical imaging, will present virtually at the 39th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2021, at 9:15 AM Eastern Time.
Butterfly Network announced in November that it will be listed on the New York Stock Exchange as BFLY in 2021 via a special purpose acquisition company merger (SPAC) with Longview Capital (NYSE: LGVW, expected to beNYSE: BFLY).
Butterfly's Chief Executive Officer, Laurent Faracci, will be joined by Dr. John Martin, Chief Medical Officer; Gioel Molinari, President; and Stephanie Fielding, Chief Financial Officer, to discuss how Butterfly plans to fundamentally improve the access and portability of ultrasound technology.
The presentation by members of the leadership team may be accessed on Butterfly's website at www.butterflynetwork.com/investors. An archived version of the webcast will be available for at least 30 days.
About Butterfly Network
Founded by Dr. Jonathan Rothberg in 2011 and led by CEO Laurent Faracci, Butterfly has created the world's first handheld, single-probe whole-body ultrasound system, Butterfly iQ. Butterfly Network's mission is to enable universal access to superior medical imaging, making high-quality ultrasound affordable, easy-to-use, globally accessible, and intelligently connected, including for the 4.7 billion people around the world lacking access to ultrasound. Through its proprietary Ultrasound-On-Chip™ technology, Butterfly Network is paving the way for earlier detection and remote management of health conditions around the world. The Butterfly iQ can be purchased online today by healthcare practitioners in the United States, Australia, Belgium, Canada, Denmark, Finland, Germany, Ireland, Italy, the Netherlands, New Zealand, Norway, Poland, Portugal, Spain, Sweden, Switzerland, and the United Kingdom.
SOURCE Butterfly Network